Research on newborn screening for treatable neonatal and childhood diseases

Research on newborn screening for treatable neonatal and childhood diseases - Research on expanded newborn screening

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045633

Enrollment

5000

Registered

2022-01-01

Start date

2022-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary immunodeficiency, spinal muscular atrophy

Interventions

screening for primary immunodeficiency and spinal muscular atrophy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: newborns undergoing current newborn screening

Exclusion criteria

Exclusion criteria: consent not available

Design outcomes

Primary

Measure	Time frame
establishment of implementation system (1 year from the start)	—

Secondary

Measure	Time frame
evaluation of efficacy (epidemiological survey in 10 years)	—

Countries

Japan

Contacts

Public ContactTomoko Mizuno

Tokyo Medical and Dental University Pediatrics

tmizuno.ped@tmd.ac.jp0338136111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026